study question: Does uterine artery embolization (UAE) permit fertility in childbearing women who have extensive symptomatic fibroids and are not eligible for surgery? summary answer: Although UAE was effective in improving bleeding, bulking and pain symptoms, and in sparing the ovarian reserve, no woman in this study delivered successfully after UAE.
Introduction
Uterine fibroids are benign tumors developed from the uterine muscle, which may be associated with heavy menstrual bleeding, pain, bladder or rectum compression and/or infertility in 25% of childbearing women (Stewart, 2001) .
Until recently, with all medical treatments being contraceptive, surgical myomectomy was the only therapeutic option available for women with symptomatic fibroids wishing to conceive (Khaund and Lumsden, 2008) . However, when fibroids are numerous and extensive, a uterus-sparing surgical treatment may be associated with significant morbidities including peri-or post-operative hemoperitoneum, requiring surgical revision and blood transfusion (LaMorte et al., 1993) , and the risk of emergency hysterectomy (Subramanian et al., 2001) or intra-abdominal adhesion formation (Dubuisson et al., 1998) which also adversely affects fertility.
Since the late 1990s, uterine artery embolization (UAE) has been developed as a new non-invasive uterus-sparing therapeutic alternative (Ravina et al., 1995) . Although effective in improving fibroid symptoms (Gupta et al., 2012) , the impact of UAE on the reproductive potential women remains a matter of debate (Myers, 2002) . Women treated with UAE have become pregnant and have had successful full-term deliveries (Pelage et al., 2000; Walker and Pelage, 2002) . However, for fertility assessment, questions on numerator (number of live births) and the denominator (number of women attempting to conceive after embolization) need to be answered by large prospective registries which are not currently available.
UAE is still controversial in women desiring pregnancy. Some authors favor UAE for women who no longer desire childbearing (Myers, 2002) , whereas others have a more permissive approach for childbearing women, offering UAE in case myomectomy is not a desirable option, either because of surgical risk, patient refusal or failure of previous surgery (Hovsepian et al., 2009) .
One of the main concerns relating to UAE is the occasional (,4%), but well-documented, risk of complications impairing fertility (Spies et al., 2002; Walker and Pelage, 2002) . Amenorrhea due to adverse effects of UAE on the ovarian reserve (Chrisman et al., 2000; Spies et al., 2002; Walker and Pelage, 2002) or on the endometrial volume (Tropeano et al., 2003) has been reported. Severe intrauterine abnormalities including the presence of tissue necrosis, fibroid protrusion (Mara et al., 2012a,b) , or uterine cavity-myoma fistula (Ogliari et al., 2005) have been described following UAE. According to experimental studies in the ewe, the use of calibrated particles of .500 mm in diameter, with a limited embolization technique (i.e. targeting the fibroid vascular network), may preserve ovarian function and fertility potential .
We report here the reproductive outcomes of a cohort of women of childbearing age wishing to conceive after definitive UAE for symptomatic fibroids. The aim was to assess the impact of this treatment on their reproductive potential.
Methods
This study was approved by the appropriate ethics committee, Comité de Protection des Personnes Ile de France XI, Saint-Germain-en-Laye, France.
Patients
This study was conducted in one French gynecology academic department (Poissy Saint Germain en Laye Hospital, Poissy, France) which is a reference center for the treatment of uterine fibroids. Between December 2006 and June 2011, each patient referred to our center for symptomatic fibroids was assessed by a gynecological surgeon working on infertility (A.T., B.P., A.F.) and an interventional radiologist specialized in embolization (J.P.P. and P.L.), and underwent magnetic resonance imaging (MRI) of the pelvis. Informed consent was obtained from all women.
We included all consecutive women of ,43 years of age, with a desire for immediate or delayed pregnancy, and requiring conservative treatment for recurrent and/or extensive symptomatic uterine fibroids. Symptoms included menorrhagia, metrorrhagia, abdominal or pelvic pain, and/or bulkrelated symptoms such as rectum or bladder compression. Therapeutic surgical alternatives were declined by a pluridisciplinary staff of expert surgeons and interventional radiologists (A.F., B.P., A.T., J.P.P., P.L.), either on the ground of fibroid recurrence despite previous surgery or because of the risk of hysterectomy or even because of patient refusal. Fibroid recurrence was defined as the reappearance of multiple fibroids (i.e. ≥3 fibroids, ≥3 cm large) at MRI after a previous myomectomy (whatever the approach). The risk of hysterectomy was estimated as high when MRI presumed that surgical cleavage plans between extensive fibroids and the little remaining healthy myometrium would be difficult to find or when severe adhesions from a previous pelvic event (surgery or infection) were suspected.
Exclusion criteria were suspicion of uterine malignant disease, hydrosalpinx, pedunculated subserosal or submucosal fibroid (confirmed by office hysteroscopy), ongoing pregnancy, serum FSH level .20 IU/l on Day 3 of the menstrual cycle, menopause or combined treatments with a scheduled myomectomy immediately following embolization, severe renal failure or allergy to contrast agents.
Before embolization, eligible women were asked to fill in a medical history, fertility and symptoms form. Their ovarian status was evaluated by hormonal dosage on Day 3 of the menstrual cycle, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), Inhibin B and AntiMüllerian hormone (AMH). MRI of the pelvis was performed including multiplanar T1-and T2-weighted spin-echo sequences, to calculate the uterine and dominant fibroid volumes, to assess the number and location of uterine fibroids and to exclude associated massive adenomyosis (i.e. judged responsible for the symptoms) or hydrosalpinx. Pre-operative infertility was defined as the absence of spontaneous conception with 2 years of attempts. The following parameters were defined as associated factors for infertility: (i) tubal anomalies and/or tubo-ovarian adhesions (regardless of their severity) diagnosed by hysterosalpingogram, laparoscopy or laparotomy, or past history of tubal plasty, of ectopic pregnancy (EP) and/or of pelvic inflammatory disease; (ii) uterine lesions including submucosal fibroids, polyps, or intrauterine synechia revealed during a previous ultrasound or hysteroscopy; (iii) anovulatory cycles or dysovulation, according to World Health Organization classification (Urman and Yakin, 2006) ; (iv) spermogram anomalies according to WHO criteria: volume ,1.5 ml; number , 15 millions/ml; progressive mobility ,40%; vitality ,58%; normal forms ,4% (Cooper et al., 2010) retrospectively applied for couples included before 2010; and (v) past history of endometriosis lesions whatever the r-AFS stage (1985) .
Procedures
The embolization procedure was performed during a short hospital stay, using patient-controlled systemic analgesia. Bilateral uterine fibroid embolization (UAE) was performed by a specialized interventional radiologist (J.P.P.), with 10 years' experience in UAE, as previously described (Pelage et al., 1999 . Briefly, both internal iliac arteries were catheterized using a 5-French Cobra catheter (Terumo, Leuven, Belgium), via 5 French single right common femoral artery access (Terumo, Leuven, Belgium). Bilateral superselective catheterization of both uterine arteries was subsequently achieved using a 2.7 French microcatheter (Terumo Progreat, Leuven, Fertility after uterine fibroid embolization Belgium). Special attention was paid to the presence of cervico-vaginal branches and uterine-to-ovarian artery anastomosis. Embolization was then performed using calibrated Tris acryl microspheres (Embosphere; Biosphere Medical, Roissy, France) of .500 mm in diameter. The embolization end-point was a pruned-tree appearance corresponding to limited UAE targeting the peri-fibroid arterial plexus and sparing normal adjacent myometrial arteries. The fluoroscopy time and radiation dose were carefully monitored.
Follow-up
Women were prospectively followed up at 2 weeks, 3 months, 6 months and 12 months after UAE and annually thereafter. Each woman lost to follow-up was contacted by telephone. If no reply was received, postal contact was attempted. Symptoms and fertility outcomes were assessed by a binary questionnaire. This form included the duration of attempts to conceive, any attempts at assisted reproductive techniques, the time of onset of pregnancy and the outcome. Pelvic MRI and hormonal dosage on Day 3 of the menstrual cycle were scheduled 3 -6 months after embolization. Each patient was contacted by telephone for a final telephone interview. During this interview, we reviewed and confirmed their attempts to conceive, any need for assisted reproduction techniques and outcomes of any pregnancies, i.e. spontaneous miscarriage, therapeutic abortion, voluntary abortion and delivery.
Post-operative fertility status was expressed as follow: spontaneous pregnancies were grouped with those obtained by ovarian stimulation or insemination, while pregnancies obtained by IVF were studied separately. An intrauterine pregnancy was defined as a positive pregnancy test with subsequent proof of intrauterine location. An ongoing pregnancy was defined as an intrauterine located pregnancy with heart activity, having reached 12 weeks of amenorrhea. A viable pregnancy was defined as a birth after 26 weeks of amenorrhea. When needed, office hysteroscopies were performed in women with infertility and/or amenorrhea after UAE.
Statistical analysis
Changes between before and after embolization were assessed using paired x 2 test or Fisher exact test for categorical variables and the paired Student t-test for continuous variables. Odds ratios and their 95% confidence interval (95% CI) were computed. P-values of ,0.05 were considered significant. For fertility assessment, we selected a particular subgroup of women who durably exposed themselves to pregnancy, by having a regular partner, regular sexual intercourse, no contraception and suitable fertility treatments when indicated. The probability of conception after UAE was estimated using the monthly fecundability rate and its confidence interval at 95% (95% CI), evaluated on the basis of the number of spontaneous conceptions per person and per month of follow-up (Cramer et al., 1979) .
Results

Studied population
During the study period, 66 women met the inclusion criteria ( Fig. 1) . None of the women declined to participate in the study. The characteristics of the study population are summarized in Table I . Previous surgery for uterine fibroids had been performed in 38 (59.4%) patients; 4 of them had had 2 different surgical approaches including a hysteroscopy. For 10 patients (15.4%), myomectomy history was limited to a hysteroscopic approach; 3 of these had associated minor adenomyosis for which UAE could also be efficient, while for 5 patients, abdominal myomectomy was regarded risky, due to extensive fibroids at MRI (3 patients), or to a history of tubal infection treated with abdominal surgery (1 patient) or to a complex myomectomy history requiring previous iterative hysteroscopies (2 patient). One patient refused any further surgical treatment for fibroids. There were 21 (32.3%) women who were considered infertile at the time of embolization and for 5 (23.8%) of these women, fibroids were the only identified cause of infertility. Although present in 15 (23.8%) patients, adenomyosis was not the dominant disease at MRI evaluation. Most patients had regular menstruation and normal ovarian function (Table II) . Other associated causes of infertility are listed in Table I .
Characteristics of the embolization are given in Table I . Both uterine arteries were successfully embolized in 62 patients (96.9%), whereas 2 patients had only one artery embolized, one because of the presence of an anatomical variation and the other because of catheterization failure. The mean volume of microspheres used was 10.5 + 8.7 ml. Three women were readmitted during the first week post embolization with fever and pain, with resolution under antibiotic therapy.
Symptom outcomes
Women were followed up for a mean period of 28.9 + 16.2 months. Among the 66 embolized women, 4 were lost to follow-up, 1 because she moved abroad and 3 for unknown reasons, leaving 62 patients (93.9%) for analysis.
After embolization, fibroid symptoms decreased dramatically for the incidence of menorrhagia (OR 0.08, 95% CI 0.02 -0.27), metrorrhagia (OR 0.05, 95% CI 0.01 -0.39), pain (OR 0.08, 95% CI 0.03 -0.22) and bulk syndrome (OR 0.02, 95% CI 0.01 -0.07, Table II ). The duration of menses was 23.8% shorter after embolization (95% CI 16.3-31.4%). At MRI performed 3-6 months after embolization, the uterine and dominant fibroid volumes were significantly reduced by 31.9% (95% CI 24.2 -39.6%) and 31.8% (95% CI 12.2 -51.3%), respectively (Table II) .
We did not observe any cases of ovarian failure within the 11.0 + 7.7 months of hormonal follow-up (Table II) . After embolization, four women became durably amenorrheic (Table II) . Two of them aged 35 and 41, respectively, presented with a low ovarian reserve before embolization (Day 3 FSH 16.7 and 17 IU/l, respectively) which persisted after embolization (Day 3 FSH 118.6 and 38.3 UI/l, respectively). The other two women aged 34 and 36 initially had a normal ovarian reserve before embolization (Day 3 FSH 7.7 and 7.1 IU/l, respectively), which remained unchanged after embolization (Day 3 FSH 6.3 and 7.1 UI/l, respectively). Two of these women were not attempting to become pregnant and appreciated their amenorrhea and did not ask for treatment. The other 2 women, aged 35 and 36, intended to become pregnant. The first woman with a previous history of both hysteroscopic and abdominal myomectomies had premature menopause and entered an oocyte donation program with 2 embryos being transferred without subsequent pregnancy (Table III) . Office hysteroscopy revealed fibrous uterine walls with no healthy endometrium. The second woman with a previous history of two abdominal myomectomies had two subsequent hysteroscopic myomectomies after UAE, complicated with uterine synechia, which was treated by a third hysteroscopy, but menstruation did not resume. In both cases, the endometrium appeared to be involved in the cause of amenorrhea.
Fertility outcomes
Among the 62 embolized women who were followed, a subgroup of 31 women (50%) actually tried to conceive with a median follow-up of 33.4 + 14.5 months (minimum 6.3 months, maximum 55.4 months, median 35.8 months, interquartile 22.5 months -43.3 months) after embolization.
Women who were actively trying to conceive were more likely to live in couples ) and to suffer from infertility (OR 10.52 95% CI 2.62-42.18). Otherwise, the different subgroups did not differ significantly with regard to age, history of previous fertility, and disease severity (symptoms, previous surgery, uterine and dominant fibroid volume), embolization parameters and clinical outcomes (Tables I  and II) . Only one woman became pregnant then finally miscarried, which resulted in a monthly fecundability rate of 0.1% (95% CI 0-0.3%). This 39-year-old woman underwent embolization because of multiple uterine fibroids with a moderate uterine volume (277 cm 3 ), responsible for menorrhagia and bulk symptoms. She had no previous surgery and had previously delivered three times. Being suspected of having a submucosal pedunculated fibroid at MRI, she underwent an office hysteroscopy which diagnosed a normal uterine cavity. Symptoms were improved and the ovarian reserve was unchanged after embolization.
At 488 days after embolization, she had a vacuum aspiration for early embryonic demise at 10 weeks of amenorrhea. Five patients resorted to in vitro fertilization with 22 embryos being transferred in all (Table III) . Three of them were initially considered infertile. The ovarian response to stimulation was variable. One of them, with two other women previously affected by premature ovarian failure, entered an oocyte donation program, with eight embryos being transferred in all. No pregnancy was obtained.
The data may suggest a deficiency in implantation capacity in these patients.
Discussion
Although effective in improving fibroid symptoms and sparing the ovarian reserve in the present study, embolization using a fertility-sparing method was not followed by any viable pregnancy in our group of women desiring pregnancy and presenting with severe symptomatic fibroids. To the best of our knowledge, our study is among the first to prospectively evaluate pregnancy attempts and pregnancy outcomes after UAE in women of childbearing age, with symptomatic fibroids and trying to conceive. It should be noted that our technique consisted of a limited embolization, leaving the main arterial trunk of the uterine arteries and myometrial branches patent. In most published studies, non-calibrated polyvinyl alcohol particles and/or small particles (,500 mm) were used McLucas et al., 2001; Walker and Pelage, 2002; Kim et al., 2005; Pron et al., 2005; Siskin et al., 2006; Walker and McDowell, 2006; Hirst et al., 2008) . It is well known that non-target tubal or ovarian embolization through patent uterine-to-ovarian artery anastomosis with a potential negative impact on the ovarian reserve (Razavi et al., 2002) may be considered an aggressive embolization technique (Tulandi et al., 2002) . The limited embolization of both uterine arteries using .500 mm tris acryl particles has demonstrated better fertility outcomes in an animal model . Moreover many of the published UAE studies reporting fertility have been retrospective and have included women past childbearing age (Table III) McLucas et al., 2001; Walker and Pelage, 2002; Pron et al., 2005; Siskin et al., 2006; Dutton et al., 2007; Pinto Pabon et al., 2008; Redecha et al., 2013) , impairing the interpretation of their fertility rate. We performed UAE according to the fertility-sparing method, prospectively following up these women of childbearing age for a long period and with a low rate of loss to follow-up, with an appropriate assessment of their fertility.
An important limitation of our study is the lack of control group with surgical treatment. Another limitation is the high frequency of associated factors responsible for the elevated infertility rate reported in the population (54.8%, Table I ). The women had a high rate of previous surgery (60%), related to our inclusion criteria, and 10% had had a myomectomy with a single hysteroscopic approach, but the cases were severe. Pelvic or intrauterine adhesions caused by a previous myomectomy may adversely affect subsequent spontaneous fertility (Fauconnier et al., 2000) . Furthermore, in cases of recurrent symptoms requiring a second line treatment after primary surgery, their uterine disease may be particularly severe, also reducing their fertility potential. Frederick et al. reported a low delivery rate (8.6% in a 2-year follow-up period) following secondary myomectomy in 58 patients (Frederick et al., 2002) . This uncontrolled study had further limitations however, including no details about the first surgical approach, nothing but a semen analysis of the spouse at inclusion, nothing about women who gave up with their will to conceive and nothing about the infertility treatments already begun. Additionally the mean patient age (37.3 years) in our study was usual for symptomatic uterine fibroids (Marshall et al., 1997) , but can adversely affect the fertility prognosis. Nevertheless, good fertility prognosis factors were also present in our population, such as the high rate of previous conceptions (64.5%) and deliveries (29%), and appropriate treatments offered to infertile women. UAE obviously did not improve the fertility potential of our patients who met generally accepted indication criteria for UAE (Hovsepian et al., 2009) . The way in which UAE may have worsened an already altered fertility potential in this population remains to be established. Our results are worse than those already reported in women wishing to conceive after UAE. Out of 6042 UAEs for fibroids in the literature, 362 pregnancies have been reported, resulting in a fertility rate of 5.8% (Table IV) . Of these pregnancies, 107 (30.1%) resulted in miscarriage during the first trimester, so the take-home baby rate (3.3%) was dramatically low. When selecting only the 738 women expressly wishing to conceive at the time of UAE, outcomes were higher than what we observed, leading to fertility, miscarriage and take-home baby rates of 36.3, 29.7 and 19.6%, respectively. Indeed, these retrospective studies took the desire for pregnancy into account retrospectively, leading to a memory bias. Moreover, women with a single myoma, whose UAE indication is questionable and whose fertility prognosis may be higher, were included. In any case, these figures compare unfavorably with the 40 -61% fertility outcome after abdominal myomectomy, which is the alternative surgical treatment (Buttram and Reiter, 1981; Vercellini et al., 1998; Donnez and Jadoul, 2002; Somigliana et al., 2007) . Women treated with UAE could be different from those treated with abdominal myomectomy, leading to an older age at the time of conception (Siskin et al., 2006; Narayan et al., 2010) , and a lower rate of pregnancy attempts (Narayan et al., 2010) , explaining in part their lower fertility outcomes. In a randomized controlled trial comparing fertility outcomes after UAE and surgical myomectomy in 121 women, Mara et al. reported a significantly lower number of conception attempts and fertility rate and a higher miscarriage rate in the embolization group , suggesting that the embolization procedure may account for these unfavorable fertility outcomes. However, several biases acted against fertility after UAE and call the results of this trial into question. Hysteroscopic exploration of the uterine cavity was only performed in its surgical part, and a fertilitysparing UAE technique was not always used (i.e. embolization using ,500 mm tris acryl microspheres in five included women). In addition, interventional radiologists at this center were in their learning curve for UAE at the time of the study.
Several causes should be considered to explain the low conception ability of the patients after UAE. One potential explanation is nontargeted ovarian embolization, impairing ovarian reserve and oocyte quality (Tulandi et al., 2002) . As markers of ovarian reserve were not significantly modified after embolization, our fertility-sparing protocol appeared safe. Another mechanism could involve a decrease in endometrial volume due to an inadequate blood supply (Tropeano et al., 2003) , which could adversely affect embryo implantation. This could also explain our four cases of amenorrhea following UAE. A healthy myometrium could also be adversely affected by embolization, leading to contraction disturbance and implantation failure (Bulletti and de Ziegler, 2005) . Specific evaluation of the endometrium and myometrium should be included in future prospective studies.
Conclusion
Although no control group was included in our study, considering our very poor reproductive outcome, a cautious attitude at present discourages the routine use of UAE in young patients with fibroid disease wishing to conceive.
The actual effect of UAE on future fertility must now be assessed in randomized trials including women with multiple symptomatic myomas but no additional infertility factor.
